Bladder Cancer Trials
Bladder
In Follow-up
BCG+MM
ANZUP 1301
NSW | VIC | QLD | WA | UK
Adding mitomycin to BCG as adjuvant intravesical therapy for high-risk, non–muscle-invasive bladder cancer: a randomised phase III trial
Bladder
In Follow-up
PCR MIB
ANZUP 1502
NSW | VIC | WA
Pembrolizumab With Chemoradiotherapy as Treatment for Muscle Invasive Bladder Cancer
Bladder
In Follow-up
NMIBC-SI Evaluation
N/A
NSW | VIC | QLD | WA | NZ | UK | Canada | USA
Developing a Patient-Reported Symptom Index for Non-muscle Invasive Bladder Cancer